Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

0.7851 +0.0851 (+12.16%)
Streaming Delayed Price Updated: 11:20 AM EDT, Aug 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 321,592
Open 0.6800
Bid (Size) 0.7701 (100)
Ask (Size) 0.8000 (5,700)
Prev. Close 0.7000
Today's Range 0.6800 - 0.8500
52wk Range 0.5011 - 1.870
Shares Outstanding 39,388,443
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
Company to reduce annual operating expenses by $17.0 million or 18% as part of broader efficiency program 
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio (TELA) Q2 2026 Earnings Call Transcript ↗
Revenue declined 4% as OviTex PRS unit volumes fell, but international sales surged 26%. 
Via The Motley Fool
Topics Earnings World Trade

Performance

YTD
-31.1%
-31.1%
1 Month
+7.6%
+7.6%
3 Month
-12.8%
-12.8%
6 Month
-8.8%
-8.8%
1 Year
-54.9%
-54.9%

More News

Read More
News headline image
TELA Bio Reports Second Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance ↗
Via Chartmill
News headline image
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce Second Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
From Biotech Insider
Via GlobeNewswire
TELA Bio Inc (NASDAQ:TELA) Reports Record Q4 Revenue but Misses Sales Estimates ↗
Via Chartmill
News headline image
TELA Bio Reports First Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce First Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Analysts Cut Their Forecasts After Q4 Results ↗
Via Benzinga
News headline image
TELA Bio (TELA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Via Chartmill

Frequently Asked Questions

Is TELA Bio, Inc. - Common stock publicly traded?
Yes, TELA Bio, Inc. - Common stock is publicly traded.
What exchange does TELA Bio, Inc. - Common stock trade on?
TELA Bio, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for TELA Bio, Inc. - Common stock?
The ticker symbol for TELA Bio, Inc. - Common stock is TELA on the Nasdaq Stock Market
What is the current price of TELA Bio, Inc. - Common stock?
The current price of TELA Bio, Inc. - Common stock is 0.7851
When was TELA Bio, Inc. - Common stock last traded?
The last trade of TELA Bio, Inc. - Common stock was at 08/31/26 11:20 AM ET
What is the market capitalization of TELA Bio, Inc. - Common stock?
The market capitalization of TELA Bio, Inc. - Common stock is 30.92M
How many shares of TELA Bio, Inc. - Common stock are outstanding?
TELA Bio, Inc. - Common stock has 31M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.